$2.13
al cierre: Aug 18 EDT
$2.05
-0.08-3.76%
Pre-comercialización: 7:54 PM EDT
Comments
Loading...
Alector Actividad de operaciones con información privilegiada
ALECNASDAQ
Actividad de operaciones de insiders
Sigue la actividad de operaciones con información privilegiada más reciente de Alector. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Alector.
¿Qué es la actividad interna?
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
¿Qué están haciendo Alector Inc los iniciados?
Los expertos no han informado de compras ni ventas en los últimos 30 días.
Compras y ventas recientes notables de información privilegiada
- El junio 23, 2025, Kristine Yaffe, la empresa - sold 1K acciones por $1.44 cada una.
- El junio 4, 2025, Marc Grasso, la empresa CHIEF FINANCIAL OFFICER sold 16.49K acciones por $1.34 cada una.
- El junio 4, 2025, Sara KenkareMitra, la empresa PRESIDENT AND HEAD R&D sold 23.89K acciones por $1.34 cada una.
Estadísticas de propiedad de Alector Inc
Acciones en circulación
101.212M
Acciones en manos de personas con información privilegiada
9.182M
Porcentaje de acciones en manos de personas con información privilegiada
9.18%
Acciones en manos de instituciones
38.983M
Porcentaje de acciones en manos de instituciones
39.0%
Jun 23, 2025 | — | -1.00K | $1.44 | -$1.44K | SELL | -1.04% | 95.41K | Jun 20 | ||
Jun 04, 2025 | CHIEF FINANCIAL OFFICER | -16.49K | $1.34 | -$22.07K | SELL | -5.28% | 296.07K | Jun 02 | ||
Jun 04, 2025 | PRESIDENT AND HEAD R&D | -23.89K | $1.34 | -$31.97K | SELL | -4.46% | 512.25K | Jun 02 | ||
Jun 04, 2025 | CHIEF EXECUTIVE OFFICER | -52.09K | $1.34 | -$69.71K | SELL | -1.67% | 3.07M | Jun 02 | ||
Mar 05, 2025 | PRESIDENT AND HEAD R&D | -29.07K | $1.47 | -$42.66K | SELL | -5.14% | 536.14K | Mar 03 | ||
Mar 05, 2025 | CHIEF EXECUTIVE OFFICER | -40.33K | $1.47 | -$59.18K | SELL | -1.28% | 3.12M | Mar 03 | ||
Mar 05, 2025 | CHIEF FINANCIAL OFFICER | -18.09K | $1.47 | -$26.55K | SELL | -5.47% | 312.56K | Mar 03 | ||
Mar 05, 2025 | CHIEF MEDICAL OFFICER | -16.31K | $1.47 | -$23.93K | SELL | -4.67% | 332.98K | Mar 03 | ||
Dec 03, 2024 | CHIEF FINANCIAL OFFICER | -16.49K | $2.52 | -$41.54K | SELL | -4.75% | 330.65K | Dec 02 | ||
Dec 03, 2024 | CHIEF EXECUTIVE OFFICER | -52.17K | $2.52 | -$131.44K | SELL | -1.62% | 3.16M | Dec 02 | ||
Dec 03, 2024 | CHIEF MEDICAL OFFICER | -14.89K | $2.52 | -$37.52K | SELL | -4.09% | 349.28K | Dec 02 | ||
Dec 03, 2024 | PRESIDENT AND HEAD R&D | -26.50K | $2.52 | -$66.76K | SELL | -4.48% | 565.22K | Dec 02 | ||
Sep 04, 2024 | CHIEF FINANCIAL OFFICER | -7.30K | $4.88 | -$35.62K | SELL | -5.29% | 130.74K | Sep 03 | ||
Sep 04, 2024 | CHIEF EXECUTIVE OFFICER | -26.50K | $4.88 | -$129.39K | SELL | -1.01% | 2.60M | Sep 03 | ||
Sep 04, 2024 | PRESIDENT AND HEAD R&D | -13.93K | $4.88 | -$67.98K | SELL | -4.56% | 291.71K | Sep 03 | ||
Sep 04, 2024 | CHIEF MEDICAL OFFICER | -8.48K | $4.88 | -$41.39K | SELL | -4.50% | 179.79K | Sep 03 | ||
Aug 23, 2024 | — | -44.25K | $5.16 | -$228.39K | SELL | -55.84% | 35.00K | Aug 22 | ||
Aug 13, 2024 | — | -10.50K | $5.06 | -$53.18K | SELL | -14.85% | 60.21K | Aug 12 | ||
Aug 13, 2024 | — | -5.00K | $5.06 | -$25.31K | SELL | -6.88% | 67.71K | Aug 12 | ||
Jun 04, 2024 | CHIEF MEDICAL OFFICER | -8.04K | $4.80 | -$38.58K | SELL | -4.10% | 188.27K | Jun 03 | ||
Jun 04, 2024 | PRESIDENT AND HEAD R&D | -13.21K | $4.80 | -$63.37K | SELL | -4.14% | 305.64K | Jun 03 | ||
Jun 04, 2024 | CHIEF EXECUTIVE OFFICER | -25.14K | $4.80 | -$120.62K | SELL | -0.95% | 2.63M | Jun 03 | ||
Jun 04, 2024 | CHIEF FINANCIAL OFFICER | -6.92K | $4.80 | -$33.21K | SELL | -4.77% | 138.04K | Jun 03 | ||
Mar 05, 2024 | CHIEF FINANCIAL OFFICER | -5.72K | $6.92 | -$39.56K | SELL | -3.79% | 144.96K | Mar 04 | ||
Mar 05, 2024 | CHIEF EXECUTIVE OFFICER | -18.84K | $6.92 | -$130.39K | SELL | -0.71% | 2.65M | Mar 04 | ||
Mar 05, 2024 | CHIEF MEDICAL OFFICER | -6.00K | $6.92 | -$41.55K | SELL | -2.97% | 196.31K | Mar 04 | ||
Mar 05, 2024 | PRESIDENT AND HEAD R&D | -10.17K | $6.92 | -$70.39K | SELL | -3.09% | 318.85K | Mar 04 | ||
Dec 06, 2023 | CHIEF FINANCIAL OFFICER | -4.57K | $5.56 | -$25.43K | SELL | -2.95% | 150.67K | Dec 04 | ||
Dec 06, 2023 | CHIEF MEDICAL OFFICER | -5.04K | $5.56 | -$27.99K | SELL | -2.43% | 202.31K | Dec 04 | ||
Dec 06, 2023 | CHIEF EXECUTIVE OFFICER | -23.83K | $5.56 | -$132.50K | SELL | -0.88% | 2.67M | Dec 04 | ||
Dec 06, 2023 | PRESIDENT AND HEAD R&D | -12.52K | $5.56 | -$69.61K | SELL | -3.67% | 329.02K | Dec 04 | ||
Sep 13, 2023 | 10% OWNER | -500.00K | $6.00 | -$3.00M | SELL | -4.40% | 10.85M | Sep 11 | ||
Sep 13, 2023 | DIRECTOR | -500.00K | $6.00 | -$3.00M | SELL | -4.39% | 10.89M | Sep 11 | ||
Sep 06, 2023 | CHIEF EXECUTIVE OFFICER | -5.65K | $5.19 | -$29.33K | SELL | -0.25% | 2.30M | Sep 05 | ||
Sep 06, 2023 | PRESIDENT AND HEAD R&D | -6.21K | $5.19 | -$32.28K | SELL | -3.37% | 177.94K | Sep 05 | ||
Sep 06, 2023 | CHIEF MEDICAL OFFICER | -2.77K | $5.19 | -$14.39K | SELL | -2.71% | 99.35K | Sep 05 | ||
Sep 06, 2023 | CHIEF FINANCIAL OFFICER | -1.11K | $5.19 | -$5.79K | SELL | -3.34% | 32.25K | Sep 05 | ||
Jun 05, 2023 | PRESIDENT AND HEAD R&D | -4.09K | $6.90 | -$28.25K | SELL | -2.17% | 184.15K | Jun 02 | ||
Jun 05, 2023 | CHIEF FINANCIAL OFFICER | -1.05K | $6.90 | -$7.25K | SELL | -3.05% | 33.36K | Jun 02 | ||
Jun 05, 2023 | CHIEF MEDICAL OFFICER | -2.62K | $6.90 | -$18.07K | SELL | -2.50% | 102.12K | Jun 02 | ||
Jun 05, 2023 | CHIEF EXECUTIVE OFFICER | -5.25K | $6.90 | -$36.28K | SELL | -0.23% | 2.30M | Jun 02 | ||
Mar 21, 2023 | CHIEF EXECUTIVE OFFICER | 27.80K | $6.22 | -$94.43K | GRANT | 1.22% | 2.31M | Mar 03 - Mar 17 | ||
Mar 03, 2023 | CHIEF MEDICAL OFFICER | -5.38K | $8.47 | -$45.61K | SELL | -4.89% | 104.74K | Dec 02 - Mar 02 | ||
Mar 03, 2023 | PRESIDENT AND HEAD R&D | -10.12K | $8.32 | -$84.22K | SELL | -5.10% | 188.24K | Mar 02 | ||
Mar 03, 2023 | CHIEF FINANCIAL OFFICER | -1.29K | $8.32 | -$10.74K | SELL | -3.62% | 34.41K | Mar 02 | ||
Mar 03, 2023 | CHIEF EXECUTIVE OFFICER | -5.85K | $8.32 | -$48.65K | SELL | -0.26% | 2.28M | Mar 02 | ||
Sep 07, 2022 | CHIEF MEDICAL OFFICER | -2.18K | $10.62 | -$23.12K | SELL | -2.36% | 90.07K | Sep 02 | ||
Sep 07, 2022 | CHIEF DEVELOPMENT OFFICER | -176.00 | $10.62 | -$1.87K | SELL | -0.03% | 529.29K | Sep 02 | ||
Jun 06, 2022 | CHIEF DEVELOPMENT OFFICER | -177.00 | $8.71 | -$1.54K | SELL | -0.03% | 529.47K | Jun 02 | ||
Mar 03, 2022 | CHIEF DEVELOPMENT OFFICER | -287.00 | $15.57 | -$4.47K | SELL | -0.05% | 528.40K | Mar 01 | ||
Dec 14, 2021 | PRESIDENT AND COO | 0.00 | $19.37 | -$640.82K | SELL-OPTIONS | 0.00% | 102.60K | Dec 10 - Dec 13 | ||
Dec 10, 2021 | PRESIDENT AND COO | 0.00 | $18.73 | -$1.22M | SELL-OPTIONS | 0.00% | 102.60K | Dec 08 - Dec 09 | ||
Dec 03, 2021 | CHIEF DEVELOPMENT OFFICER | -250.00 | $20.09 | -$5.02K | SELL | -0.05% | 528.69K | Dec 01 | ||
Nov 12, 2021 | CHIEF EXECUTIVE OFFICER | -110.00K | $25.00 | -$2.75M | SELL | -3.11% | 3.43M | Nov 10 - Nov 11 | ||
Nov 10, 2021 | CHIEF EXECUTIVE OFFICER | -200.00K | $25.00 | -$5.00M | SELL | -8.67% | 2.11M | Nov 08 - Nov 09 | ||
Nov 08, 2021 | CHIEF EXECUTIVE OFFICER | -200.00K | $25.00 | -$5.00M | SELL | -8.56% | 2.14M | Nov 04 - Nov 05 | ||
Sep 23, 2021 | CHIEF EXECUTIVE OFFICER | -109.63K | $25.31 | -$2.77M | SELL | -3.51% | 3.02M | Sep 22 - Sep 23 | ||
Sep 22, 2021 | CHIEF EXECUTIVE OFFICER | -200.00K | $25.96 | -$5.19M | SELL | -6.02% | 3.13M | Sep 20 - Sep 21 | ||
Aug 11, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $18.93 | -$378.52K | SELL-OPTIONS | 0.00% | 234.32K | Aug 09 | ||
Aug 09, 2021 | DIRECTOR | -9.98K | $19.17 | -$1.30M | SELL | -100.00% | 0.00 | Jul 02 - Aug 05 | ||
Jul 08, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $26.33 | -$1.39M | SELL-OPTIONS | 0.00% | 234.32K | Jul 06 - Jul 07 | ||
Jul 07, 2021 | VICE PRESIDENT, FINANCE | -50.00K | $22.96 | -$2.90M | SELL | -39.47% | 76.69K | Jul 02 - Jul 06 | ||
Jul 07, 2021 | CHIEF DEVELOPMENT OFFICER | 0.00 | $20.14 | -$1.32M | SELL-OPTIONS | 0.00% | 522.32K | Jul 02 | ||
Jul 06, 2021 | CHIEF MEDICAL OFFICER | -39.40K | $22.05 | -$1.23M | SELL | -14.39% | 234.32K | Jul 01 - Jul 02 | ||
Jun 21, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $15.62 | -$447.02K | SELL-OPTIONS | 0.00% | 273.72K | Jun 15 - Jun 16 | ||
Jun 10, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $14.28 | -$187.75K | SELL-OPTIONS | 0.00% | 273.72K | Jun 08 | ||
Jun 03, 2021 | VICE PRESIDENT, FINANCE | -1.84K | $17.77 | -$32.77K | SELL | -1.43% | 126.69K | Jun 02 | ||
May 25, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $13.20 | -$147.93K | SELL-OPTIONS | 0.00% | 273.72K | May 21 | ||
May 20, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $13.41 | -$38.94K | SELL-OPTIONS | 0.00% | 273.72K | May 18 | ||
Apr 08, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $14.40 | -$213.86K | SELL-OPTIONS | 0.00% | 213.72K | Apr 07 | ||
Mar 24, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $15.45 | -$638.47K | SELL-OPTIONS | 0.00% | 213.72K | Mar 22 - Mar 23 | ||
Mar 10, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $13.25 | -$186.81K | SELL-OPTIONS | 0.00% | 213.72K | Mar 09 | ||
Feb 11, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $14.59 | -$238.46K | SELL-OPTIONS | 0.00% | 213.72K | Feb 09 | ||
Jan 27, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $13.19 | -$551.76K | SELL-OPTIONS | 0.00% | 213.72K | Jan 25 - Jan 26 | ||
Jan 21, 2021 | CHIEF MEDICAL OFFICER | 0.00 | $13.23 | -$374.81K | SELL-OPTIONS | 0.00% | 213.72K | Jan 19 - Jan 20 |
PREGUNTAS FRECUENTES
¿Es legal el uso de información privilegiada?
Las operaciones con información privilegiada son legales siempre que se notifiquen a la Comisión de Bolsa y Valores (SEC). El comercio ilegal de valores se produce cuando la persona con información privilegiada viola un deber fiduciario o no informa de sus operaciones.
¿Cuáles son algunos ejemplos de manipulación del mercado?
Las operaciones con información privilegiada, los esquemas de pump and dump, el front running y las operaciones de lavado son ejemplos de manipulación del mercado. Los inversores que siguen el movimiento de activos con información privilegiada deben pensar atentamente por qué estos operadores con información privilegiada están negociando sus acciones antes de seguir adelante.
Explora operaciones con información privilegiada sobre todos los valores.